Direct-to-Patient Prescription Drug Platforms: What Should Cardiologists Know?

J Am Coll Cardiol. 2026 Jun 10:S0735-1097(26)06491-0. doi: 10.1016/j.jacc.2026.04.048. Online ahead of print.

¹ Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
² Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
³ Richard A. and Susan F. Smith Center for Outcomes Research, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. Electronic address: rwadhera@bidmc.harvard.edu.

No abstract available

Keywords: cardiovascular disease; direct-to-patient platforms; medication access; prescription drug pricing.